Flu Vaccine Act
HR 6184, the Flu Vaccine Act, authorizes $200 million annually from 2024 through 2029 to fund research at the National Institute of Allergy and Infectious Diseases (NIAID) aimed at developing a universal influenza vaccine. This research seeks a single vaccine effective against all flu strains, rather than requiring yearly updates. The bill directly affects NIAID scientists and future vaccine development efforts by providing dedicated funding for this specific goal. It does not change current vaccine distribution or affect individual patients or healthcare providers.
Bill status
in committee
1 of 4 stages cleared
Introduction
Nov 2023
Committee Review
Floor Vote
President
Introduced Nov 2, 2023
Last action Nov 3, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Nov 3, 2023
Committee
Referred to the Subcommittee on Health.
lower
Nov 2, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Nov 2, 2023
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Rosa L. DeLauro
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 6184
Scope: US
Hi! I can help you understand HR 6184. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline